BioSpace News Archive

Business

DATATRAK Reports Third Quarter Results of 2017

DATATRAK reduced its direct costs by 15% and its SG&A expenses by 1% for the three months ended September 30, 2017 compared to the three months ended September 30, 2016.

November 2, 2017
·
14 min read
Business

Genocea Reports Third Quarter 2017 Financial Results

The company reported financial results for the third quarter of 2017 and announced upcoming data presentations at a leading immuno-oncology conference.

November 2, 2017
·
10 min read
Biotech Beach

Klotho Therapeutics Targets Kidney Disease With Series A Financing

Proceeds of the financing will fund KTI’s manufacturing scale-up, first in-human studies and IND application with the FDA.

November 2, 2017
·
2 min read
BioMidwest

UROMEDICA Announces Successful First US Commercial Implant of ProACT Adjustable Continence Therapy for Men

The procedure was carried out by Dr. Steven Nash in Overland Park, KC.

November 2, 2017
·
2 min read
Business

Tetraphase Pharmaceuticals Reports Third Quarter 2017 Financial Results and Highlights Recent Clinical and Corporate Achievements

The company reported financial results for the third quarter ended September 30, 2017 and provided an overview of recent achievements.

November 2, 2017
·
8 min read
Dr. Reddy’s Laboratories Announces the Launch of Generic Azacitidine for Injection in the Canadian Market

Dr. Reddy’s Laboratories is pleased to announce that generic Azacitidine for injection 100 mg/vial, a bioequivalent generic version of VIDAZA (azacitidine for injection), is approved by Health Canada.

November 2, 2017
·
3 min read
Business

Altimmune to Announce Third Quarter 2017 Financial Results on November 9

November 2, 2017
·
1 min read
Tigenix Strengthens European IP Protection Around Lead Development Program Cx601

The use of Cx601 in treating fistulas is protected by European patent EP 2292737 entitled “Use of adipose tissue-derived stromal stem cells in treating fistula”.

November 2, 2017
·
6 min read
Argenx to Host KOL Breakfast Symposium on Pemphigus Vulgaris on November 10, 2017

The event will feature guest speaker Dr. John Stanley, M.D., University of Pennsylvania School of Medicine, who will highlight the treatment landscape and unmet need in PV.

November 2, 2017
·
3 min read
Business

Senomyx Reports Third Quarter 2017 Financial Results

“In the third quarter, we exceeded our quarterly financial guidance, made significant progress on the monetization of certain flavor assets through our strategic advisor and advanced our discussions towards establishing new collaborative research funding.”

November 2, 2017
·
13 min read